Athenex raises $66M in IPO

On June 14, cancer company Athenex Inc. (NASDAQ:ATNX) raised $66 million through the sale of 6 million shares at $11 in an IPO underwritten by Credit Suisse, Deutsche Bank, JPMorgan and ICBC Internat...